OS Therapies Incorporated

OSTXAMEX · Pharmaceutical Preparations

Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

45.3M

on 2026-06-30, from 5.99M on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-2 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

S-3 of 2025-08-08. Not read yet. S-3 ↗

$75.0M

Agreement of 2026-08-21. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

510K

Warrants of every class as tagged in the XBRL facts on 2024-09-30. 10-Q ↗

Cash

under 0.1 quarters

$205K on 2026-06-30 ÷ $4.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-08-06	Public offering	500,000	not read	not read	424B5 ↗
2026-03-31	Public offering incl. 1.25M pre-funded	3,755,966	$1.40	$5.3M	424B5 ↗
2026-03-31	Registered direct offering incl. 1.25M pre-funded	3,755,966	not read	not read	8-K ↗
2026-03-04	Private placement	1,666,667	not read	$2.0M	8-K ↗

Also on file: $2.2M convertible notes, 2026-03-04 8-K ↗ · $1.6M convertible notes, 2026-06-30 8-K ↗ · up to $10.0M convertible notes agreed 2026-07-02 8-K ↗ · $5.4M convertible notes, 2026-08-10 8-K ↗